recent experiments, cannabis can be a powerful tool for patients with multiple sclerosis are diagnosed. While at first the symptomatic improvement in patients with multiple sclerosis who have been cannabinoid products experienced were administered are probably determined only by psychological factors, the subsequent research showed that cannabis actually reduces muscle spasms and stiffness characteristic of multiple sclerosis patients. The beneficial effects of cannabis have been in patients with multiple sclerosis by short-term and long-term controlled medical studies confirmed.

In 2003, a team of researchers from the Peninsula Medical School in Exeter, UK have made public the results of a series of short-term and long-term studies on the effects of cannabinoids in patients with multiple sclerosis. Studies conducted to date involved the active participation of around 600 patients with advanced multiple sclerosis. Participants were divided into two groups: The first group received cannabinoid compounds in equal doses, while the second group received placebo medication for a period of 15 weeks. By the end of the experiment, in the majority of patients, the cannabinoids were given significant symptomatic improvement with less muscle pain and is confronted with mild spasticity (less pronounced muscle spasms). In contrast to the group that cannabinoid compounds have received over the entire period of the study, experienced in the control group (patients who received placebo medication) no improvement in her general condition.

To confirm the relevance of the results and any doubts about the effectiveness of cannabis in ameliorating the symptoms of multiple sclerosis to discard, the study was repeated later. The ulterior study was conducted over a period of 12 months and involved the participation of the same topics. But this time the participants were divided into three different groups instead of two as in the case of the previous experiment. The first group received pills of D9-tetrahydrocannabinol (THC) the active component in cannabis, the second group received natural cannabis extracts, while the third group received placebo medication.

At the end of the trial, patients were carefully evaluated and tested by a team of physiotherapists and neurologists. The best results were obtained in the patients of the first study group, have received the majority of the subjects, the same doses of THC, experienced significant improvements in their symptoms. The patients in the second study group of experienced modest improvements in symptoms, while the third group of patients felt no change in her condition.

Despite the fact these studies show clearly that cannabis an effective way to treat multiple sclerosis, doctors are still not convinced that cannabinoids are successfully used in the treatment of multiple sclerosis. But after additional studies on the matter and costly research, to check the doctors to cannabinoid compounds in the treatment of multiple sclerosis result in the near future.

We recommend adding this site http: / / www. Multiple Sclerosis Centre. com for other topics such as multiple sclerosis treatment of multiple sclerosis or symptoms of multiple sclerosis